Skip Navigation LinksHome > December 2011 - Volume 5 - Issue 4 > Understanding and Treating Comorbid Anxiety Disorders in Sub...
Text sizing:
A
A
A
Journal of Addiction Medicine:
doi: 10.1097/ADM.0b013e31823276d7
Review

Understanding and Treating Comorbid Anxiety Disorders in Substance Users: Review and Future Directions

Wolitzky-Taylor, Kate PhD; Operskalski, Joachim T. BA; Ries, Richard MD; Craske, Michelle G. PhD; Roy-Byrne, Peter MD

Collapse Box

Abstract

Anxiety disorders commonly occur among those with substance use disorders. This article reviews the literature describing the prevalence and patterns of this comorbidity in epidemiological and clinical samples and theoretical models explaining this comorbidity, and reviews the effects of anxiety disorders on substance use outcomes and data from clinical trials that target comorbid anxiety disorders to examine the effects of treating anxiety disorders on substance use outcomes. Next, this review outlines evidence-based pharmacological and psychological treatments for anxiety disorders and provides treatment recommendations for those treating this comorbid population. Finally, a discussion of treatment-delivery issues is presented to address the important issues that arise when treating anxiety disorders in typical addictions-treatment settings.

© 2011 American Society of Addiction Medicine

    

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.